Arthrolense, a company pioneering a machine vision and machine learning-based surgical guidance in orthopedics, began a strategic partnership with Waldemar Link to introduce their respective technologies to the orthopedic community.

Arthrolense and Link will partner to drive innovation of the Arthrolense 4Di visual guidance system with Link’s LinkSymphoKnee primary knee system, as well as other advanced knee implant solutions in revision knee indications.

Link’s knee systems will be enhanced by Arthrolense’s real-time surgical visualization and mapping to provide surgeons with advanced visual guidance and actionable, patient-specific insights during surgical planning and component placement. Shared surgeon networks can be used to increase market awareness and adoption of the products and technologies.

This collaboration hopes to reduce surgical variability, improve implant positioning, and support better post-op outcomes for patients undergoing joint arthroplasty.

“We are excited to partner with Link to bring the power of Arthrolense’s advanced technology into everyday surgical practice,” said Arthrolense CEO Oren Gelman, who was appointed last month. “This collaboration is a major step forward to deliver Arthrolense’s 4Di system for the benefit of surgeons and patients in the U.S.”

“At Link, our unwavering commitment to innovation is driven by a singular purpose: improving the quality of life for patients worldwide,” added LINK Group CEO Peter Willenborg. “This partnership with Arthrolense exemplifies how cutting-edge technology can empower surgeons with real-time insights and precision tools—enhancing surgical outcomes and consistency. By integrating our advanced LinkSymphoKnee implant systems with Arthrolense’s visual guidance platform, we are taking a decisive step toward more personalized, predictable, and successful orthopedic procedures.”